Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI) -- Ignore unavailable to you. Want to Upgrade?

To: Starlight who wrote (538)	1/11/2000 5:24:00 PM
From: OldAIMGuy	Read Replies (1) \| Respond to of 1154

Hi Betty, I think quite a bit of GENE's potential will be realized only if the general BIO sector remains strong. It will do as it always has, try to write good collaborative deals and keep the books balanced. I'm currently holding about 19% Cash Reserve for GENE. I'd like it a bit higher, but it's been a moving target for me. As recent as September my GENE account was 100% invested. Of course the price was only about $4 to $4-1/2 then. The rapid boost in share price after such a long quiet spell has my program begging for me to raise cash. I've been piecing out the shares slowly while trying to get a feel of what's coming. I managed to sell 5% of my position today at $20-1/4, so I'm one of the profit takers. However that still leaves a large number of shares in my core holding. Yes, GENE could drop back a long way if the market gets stinky. I'd like to think we've not seen the year's high yet. Time will tell. Best regards, Tom